AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference48 articles.
1. Predictive value of serum testosterone for type 2 diabetes risk assessment in men;Atlantis;BMC Endocr. Disord.,2016
2. The interdependence of renal epithelial and endothelial metabolism and cell state;Balzer;Sci Signal.,2020
3. The role of RKIP in the regulation of EMT in the tumor microenvironment;Cessna;Cancers,2022
4. Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling;Chang;Cell Death Dis.,2022
5. Endothelial-to-mesenchymal transition drives atherosclerosis progression;Chen;J. Clin. Invest.,2015
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Direct targeting of S100A9 with Icariin counteracted acetaminophen‑induced hepatotoxicity;International Immunopharmacology;2024-07
2. Shenqi Pill Mitigates Renal Interstitial Fibrosis Through Weakening Notch1/Jag1 Pathway;IRAN J KIDNEY DIS;2024
3. Exploring the molecular mechanism of Epimedium brevicornu Maxim. in treating breast cancer via network pharmacology and in vitro experiments;Journal of Traditional Chinese Medical Sciences;2024-04
4. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: An update since 2010;Pharmacological Research;2024-02
5. Molecular mechanisms and therapeutic potential of natural flavonoids in diabetic nephropathy: Modulation of intracellular developmental signaling pathways;Current Research in Pharmacology and Drug Discovery;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3